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  Executive Summary 
 
 Drinking water utilities provide an exceedingly important public health service through 
their generation of high quality, safe and palatable tap water. The disinfection of drinking water 
in public facilities primarily employs chemical disinfectants such as chlorine, chloramines, ozone 
and chlorine dioxide. These disinfectants are oxidants that convert naturally occurring and 
synthetic organic material, bromide, and iodide in the raw water into chemical disinfection by-
products (DBPs). DBPs are an unintended consequence and were first discovered over 30 years 
ago. Each disinfection method generates a different spectrum and distribution of DBPs; to date 
over 600 DBPs have been identified. While reducing the public health risk of acute infection by 
waterborne pathogens, the unintended generation of DBPs poses a chronic health risk. DBPs 
represent an important class of environmentally hazardous chemicals that are regulated by the 
U.S. Environmental Protection Agency (U.S. EPA) and carry long-term human health 
implications. Epidemiological studies demonstrated that individuals who consume chlorinated 
drinking water have an elevated risk of cancer. DBPs have been linked to reproductive and 
developmental effects, including the induction of spontaneous abortions in humans.  
 Although chlorine has been used for over 100 years in the United States as a water 
disinfectant, the majority of DBPs present in drinking water have yet to be chemically 
characterized. With only approximately 30% of the total organic halide identified to specific 
DBP chemical classes, and a small fraction of these evaluated for their biological and 
toxicological effects, it is clear that a great deal of work remains in the characterization of DBPs.  
 A comparative, in vitro analysis measured chronic cytotoxicity and acute genomic DNA 
damage in Chinese hamster ovary (CHO) cells induced by three chemical classes of emerging 
DBPs. Haloacetonitriles and haloacetamides (nitrogen-containing DBPs) and haloacetaldehydes 
(carbon-based DBPs) were evaluated such that a rank order of their chronic cytotoxicity to CHO 
cells was generated. For the haloacetonitriles the cytotoxicity from most toxic to least toxic was 
dibromoacetonitrile > bromoacetonitrile > ≈ iodoacetonitrile > bromochloroacetonitrile > 
dichloroacetonitrile > chloroacetonitrile > trichloroacetonitrile. The cytotoxicity order for the 
haloacetamides was diiodoacetamide > iodoacetamide > bromoacetamide > tribromoacetamide > 
bromoiodoacetamide >  dibromochloroacetamide > bromochloroacetamide > 
chloroiodoacetamide > bromodichloroacetamide  > dibromoacetamide > chloroacetamide > 
dichloroacetamide > trichloroacetamide. Finally the order of cytotoxicity for the 
haloacetaldehydes was tribromoacetaldehyde ≈ chloroacetaldehyde > dibromoacetaldehyde > 
dichloroacetaldehyde >> trichloroacetaldehyde. The induction of genomic DNA damage by these 
DBPs was quantitatively measured using single cell gel electrophoresis (SCGE) analysis. The 
rank order for the genotoxicity of the haloacetonitriles was iodoacetonitrile > bromoacetonitrile ≈ 
dibromoacetonitrile > bromochloroacetonitrile > chloroacetonitrile > trichloroacetonitrile > 
dichloroacetonitrile. The rank order for the genotoxicity of the haloacetamides was 
tribromoacetamide > diiodoacetamide ≈ iodoacetamide > bromoacetamide > 
dibromochloroacetamide > bromoiodoacetamide > bromodichloroacetamide > 
chloroiodoacetamide > bromochloroacetamide > dibromoacetamide > chloroacetamide > 
trichloroacetamide with dichloroacetamide not genotoxic. The genotoxic rank order for the 
haloacetaldehydes was chloroacetaldehyde ≈ dibromoacetaldehyde > tribromoacetaldehyde > 
dichloroacetaldehyde. Trichloroacetaldehyde was not genotoxic. These data demonstrate the 
wide range of responses by these emerging and important DBPs. The selection of these three 
DBP classes was based on information from recent U.S. EPA DBP priority and occurrence 
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studies. Mammalian cell cytotoxicity and genotoxicity data provided a rank ordering of the 
relational toxicities of regulated and emerging DBPs and related agents both within an individual 
chemical class and among classes. The use of alternative disinfectants generates new DBP 
compounds and alters the distribution of DBP chemical classes. The water supply community 
will be able to consider these factors when employing alternatives to chlorine disinfection. In 
addition these data will be available to prioritize DBPs for future in vivo toxicological studies 
and risk assessment. 
 3
Introduction 
 
 One of the most important and perhaps the most significant public health achievement of 
the twentieth century was the disinfection of drinking water and its distribution infrastructure [1]. 
In a recent paper Dr. Mark Shannon, Director of the University of Illinois WaterCAMPWS 
Program stated, “One of the most pervasive problems afflicting people throughout the world is 
inadequate access to clean water and sanitation. Problems with water are expected to grow worse 
in the coming decades, with water scarcity occurring globally, even in regions currently 
considered water-rich. Addressing these problems calls out for a tremendous amount of research 
to be conducted to identify robust new methods of purifying water at lower cost and with less 
energy, while at the same time minimizing the use of chemicals and impact on the environment” 
[2].  
 The public drinking water community provides an exceedingly important public health 
service for the nation by its generation of high quality, safe and palatable tap water. Each day 
approximately 250,000 public water purification facilities in the United States provide over 
1.3×1010 liters of high quality, drinking water to over 270 million Americans [3]. The disinfection 
of drinking water in public facilities primarily uses chemical disinfectants such as chlorine, 
chloramines, ozone and chlorine dioxide [4, 5]. These disinfectants are also oxidants that convert 
naturally occurring and synthetic organic material, bromide, and iodide in the raw water into 
chemical disinfection by-products (DBPs). DBPs are an unintended consequence and were first 
discovered over three decades ago [6, 7]. Each disinfection method generates a different 
spectrum and distribution of DBPs [5, 8]; to date over 600 DBPs have been identified [9, 10]. 
While reducing the public health risk of acute infection by waterborne pathogens, the generation 
of DBPs poses a chronic health risk. DBPs represent an important class of environmentally 
hazardous chemicals that carry long-term human health implications [3, 10-14]. Epidemiological 
and laboratory based studies demonstrated that individuals who consume chlorinated drinking 
water have an elevated risk of cancer of the bladder, stomach, pancreas, kidney, and rectum as 
well as Hodgkin’s and non-Hodgkin’s lymphoma [15-34]. DBPs have been linked to deleterious 
reproductive and developmental effects [10, 35-39], including the induction of spontaneous 
abortions in humans [40-49].  
 Although chlorine has been used for over 100 years as a water disinfectant, the majority 
of DBPs present in drinking water have yet to be chemically defined [5, 8, 50-52]. Identified 
DBPs account for less than 50% of the total organic halide (TOX) produced in chlorinated 
drinking water. Many drinking water disinfection facilities use multiple chemical disinfection 
methods. A summary of the percentages of DBP classes in water surveyed in the U.S. EPA 
Nationwide Occurrence Study is presented in Figure 1 [50]. With only approximately 30% of the 
total organic halide identified to specific DBP chemical classes, it is clear that a great deal of 
work remains in the characterization of DBPs.  
  
Evolving U.S. EPA Regulations 
 In 1979 the U.S. EPA issued a regulation to control total trihalomethanes (chloroform, 
bromodichloromethane, dibromochloromethane, and bromoform) at an annual average of 100 
μg/L (ppb) in drinking water [53]. In 1998 the U. S. EPA issued the Stage 1 Disinfectants 
(D)/DBP Rule, which lowered permissible levels of total THMs to 80 μg/L and regulated five 
haloacetic acids (chloro-, dichloro-, trichloro-, bromo-, and dibromoacetic acids) at 60 μg/L, 
bromate at 10 μg/L, and chlorite at 1000 μg/L [54]. Stage 1 regulations required monitoring 
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based on running annual averages in a utility’s distribution system. Recently the Stage 2 D/DBP 
Rule was enacted that maintained the Stage 1 Rule maximum contaminant levels (MCLs) for the 
DBPs plus the additional restriction that the MCLs are based on locational running annual 
averages [55]. The Stage 2 D/DBP Rule maintains the MCLs for bromate and chlorite; however, 
the U.S. EPA plans to review the bromate MCL as part of their 6-year review process. Besides 
the United States, the United Nations World Health Organization has issued guidelines for DBPs 
[12] as well as the European Union [56]. 
 
 
 As a result of the more stringent effluent limitations on THMs and HAAs embodied in 
the U.S. Environmental Protection Agency’s Disinfection By-Products Rule, drinking water 
utilities are in the process of incorporating different disinfectant combinations, particularly the 
use of chloramination and ozonation, to minimize THM and HAA formation. While these 
strategies effectively reduce the formation of these regulated DBPs [5, 8], recent findings 
indicate that they may foster the formation of highly toxic N-DBPs. For example, nitrosamines 
form primarily during chloramination [57-60]. Ozonation followed by chlorination significantly 
enhances the formation of chloropicrin, a member of the nitroalkane family [61, 62]. Because 
utilities are altering their disinfection protocols, there is a current need for research regarding 
Unknown 69.9%
THMs 13.5%
HAAs 11.8%
Halofuranones 0.1%
IodoTHMs 0.2%
HANs 0.8%
HALDs 1.8%
HKs 0.9%
HACEs 0.5%
HNMs 0.5% 
Figure 1. Summary distribution of DBP chemical classes in water analyzed in the U.S. EPA 
Nationwide Occurrence Study as a component of TOX . The abbreviations are THMs = 
trihalomethanes, HAAs = haloacetic acids, HNMs = halonitromethanes, HACEs = 
haloacetamides, HKs = haloketones, HALDs = haloacetaldehydes, HANs = haloacetonitriles.  
Data summarized from the U.S. EPA Nationwide Occurrence Study [50]. 
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disinfection methodologies that minimize N-DBP formation. These data indicate that unknown 
and potentially hazardous novel DBPs may be generated by using alternative disinfection 
methods especially when heightened levels of bromine or iodine are present in the raw waters. 
 
Emerging Health Concerns Related to Nitrogen-Containing DBPs 
 Several recent developments point to emerging important, and quantifiable, human health 
risks.  Moreover, these developments promise new, exciting avenues for research that could lay 
the groundwork for an overhaul in the methods by which DBP regulations are developed. First, 
alterations in source water quality are resulting in the formation of new DBP families that exhibit 
far higher toxicities than the carbon-based trihalomethane (THM) and haloacetic acid (HAA) 
disinfection byproducts (C-DBPs) that are currently regulated. The decreasing availability of 
pristine waters supplies fostered by population growth is encouraging utilities to exploit waters 
impaired by agricultural runoff or wastewater effluents [63].  Whether via direct dissolved 
organic nitrogen (DON) inputs from wastewater effluents or via algal blooms fostered by 
inorganic nitrogen loadings from agricultural runoff, such waters often feature higher DON 
concentrations [64] that serve as precursors for nitrogen-containing DBPs (N-DBPs). Of 
particular concern due to their toxicities are N-DBPs featuring nitro (-NO2; e.g., 
halonitromethanes), nitrile (-CN; e.g., haloacetonitriles), nitroso (-NO; e.g., N-
nitrosodimethylamine (NDMA), and amine (-CNH2; e.g. haloacetamides) functional groups. For 
example the haloacetonitriles constitute 10% of the 50 DBPs predicted to be the most 
carcinogenic [65]. The U.S. EPA estimates that drinking water concentrations of nitrosamines as 
low as 10−12 M would result in a 10−6 lifetime cancer risk [66].   
 Combining recent advances in analytical biology with our emerging knowledge regarding 
alterations in source water quality may enable the avoidance of one of the major pitfalls that had 
befallen prior C-DBP research: the inability to predict the most important C-DBPs likely to form, 
and to quantify their toxicological importance. While >600 C-DBPs have been identified over 
the past 30 years, these compounds account for only ~ 40% of the total organic halides (TOX) in 
chlorinated drinking waters [50]. With ozonation and chloramination, the percentage of 
unidentified TOX is even higher (i.e., > 80%) [5, 8].  
 
Research Objectives 
 In this project we applied in vitro mammalian cell chronic cytotoxicity, genomic DNA 
damage and acute cytotoxicity assays to investigate two important emerging classes of nitrogen-
containing DBPs (N-DBPs) the haloacetonitriles and the haloacetamides as well as an emerging 
class of poorly studied C-DBPs, the haloaldehydes. With changing disinfection practices the 
formation of these emerging DBPs deserves attention by managers of drinking water utilities in 
Illinois and the nation. 
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Materials and Methods 
 
Biological and Chemical Reagents 
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma 
Chemical Co. (St. Louis, MO). Media and fetal bovine serum (FBS) were purchased from 
Hyclone Laboratories (Logan, UT) or from Fisher Scientific Co. (Itasca, IL). 
 
Chinese Hamster Ovary Cells 
 Chinese hamster ovary (CHO) cells are widely used in toxicology. The transgenic CHO 
cell line AS52 [67, 68] was derived from the parental CHO K1-BH4 line [69, 70]. Clone 11-4-8 
was isolated from AS52 by Dr. E. Wagner and it expresses a stable chromosome complement, a 
consistent cell doubling time as well as functional p53 protein [71-73].  
 
Selection and Source of DBPs and Associated Chemical Agents 
 A major problem for the toxicological analysis of emerging DBPs is that the large 
majority of the agents listed by Woo et al. [74] and Krasner et al. [50] are not commercially 
available. However, through collaboration with Dr. Susan Richardson, U. S. EPA, and with 
support from the American Water Works Research Foundation, most of the priority DBPs were 
synthesized as analytical standards and were provided for this study. Reagent grade or higher 
chemical agents were purchased from commercial vendors when available. The DBPs and 
related chemicals were shipped to the laboratory, logged into a database, and usually stored in 
dark conditions at 4°C. Prior to the biological experiments a 1 M or a 2 M solution of the DBP 
was prepared in dimethylsulfoxide (DMSO). This stock solution was immediately stored under 
dark conditions at −22°C. For each experiment freshly prepared serial dilutions into Hams F12 
medium were made to treat the mammalian cells. A list of the sources and purities of the DBPs 
and related chemicals analyzed in this study is presented in Table 1. 
 
Table 1. Sources and purities of the DBPs and related chemical agents used in the in vitro CHO cell 
toxicity assays for this project. 
DBP or Chemical Agent Chemical Class MW Purity 
% 
Source 
Bromoacetonitrile Halonitrile 119.95 97 Chem. Service 
Bromochloroacetonitrile Halonitrile 154.39 >95 Chem. Service 
Chloroacetonitrile Halonitrile 75.50 >99 Chem. Service 
Dibromoacetonitrile Halonitrile 198.84 97 Chem. Service 
Dichloroacetonitrile Halonitrile 109.94 >99 Chem. Service 
Iodoacetonitrile Halonitrile 166.95 98 CanSyn Chem. Co. 
Trichloroacetonitrile Halonitrile 144.39 98 Aldrich Chem. Co. 
Bromoacetamide Haloamide 137.96 98 U.S. EPA 
Bromochloroacetamide Haloamide 172.41 >99 CanSyn Chem. Co. 
Bromodichloroacetamide Haloamide 206.85 >95 CanSyn Chem. Co. 
Bromoiodoacetamide Haloamide 263.86 85 CanSyn Chem. Co. 
Chloroacetamide Haloamide 93.51 >95 U.S. EPA 
Chloroiodoacetamide Haloamide 219.41 >95 CanSyn Chem. Co. 
Dibromoacetamide Haloamide 216.86 >95 CanSyn Chem. Co. 
Dibromochloroacetamide Haloamide 251.31 >95 CanSyn Chem. Co. 
Dichloroacetamide Haloamide 127.96 98 U.S. EPA 
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Table 1. Sources and purities of the DBPs and related chemical agents used in the in vitro CHO cell 
toxicity assays for this project. 
DBP or Chemical Agent Chemical Class MW Purity 
% 
Source 
Diiodoacetamide Haloamide 310.85 >99 CanSyn Chem. Co. 
Iodoacetamide Haloamide 184.96 >97 Sigma Chem. Co. 
Tribromoacetamide Haloamide 295.75 >95 CanSyn Chem. Co. 
Trichloroacetamide Haloamide 162.40 99 U.S. EPA 
Chloroacetaldehyde Haloaldehyde 78.50 >95 CanSyn Chem. Co. 
Dibromoacetaldehyde Haloaldehyde 201.85 >95 CanSyn Chem. Co. 
Dichloroacetaldehyde Haloaldehyde 112.94 >95 CanSyn Chem. Co. 
Tribromoacetaldehyde Haloaldehyde 280.74 97 CanSyn Chem. Co. 
Trichloroacetaldehyde Haloaldehyde 165.40 >95 CanSyn Chem. Co. 
 
Maintenance of CHO Cells 
 Stock cultures of the CHO cells were frozen in a solution of 90% fetal bovine serum 
(FBS):10% dimethylsulfoxide (DMSO) (v/v) and stored at −80°C. Cells were grown on glass 
culture plates in Hams F12 medium plus 5% FBS at 37°C in a humidified atmosphere of 5% CO2. 
The cells exhibit normal morphology, express cell contact inhibition and grow as a monolayer 
without expression of neoplastic foci. CHO cells were transferred when the culture became 
confluent. 
 
CHO Cell Chronic Cytotoxicity Assay 
 The CHO cell microplate chronic cytotoxicity assay measures the reduction in cell density as 
a function of the concentration of the test agent over a 72 h period [75, 76]. A 96-well flat-
bottomed microplate was used to evaluate a series of chemical concentrations. One column 
served as the blank control consisting of 200 μL of F12 +FBS medium only. The concurrent 
negative control column consisted of 3×103 CHO cells plus F12 +FBS medium. The wells of the 
remaining columns contained 3×103 CHO cells, F12 +FBS and a known DBP concentration in a 
total of 200 μL (Figure 2). The wells were covered with a sheet of sterile AlumnaSeal™ and the 
cells were incubated for 72 h at 37°C at 5% CO2. After the treatment time, the medium from each 
well was aspirated, the cells fixed in methanol for 10 min and stained for 10 min with a 1% 
crystal violet solution in 50% methanol. The microplate was washed, 50 μL of DMSO/methanol 
(3:1 v/v) were added to each well, and the plate was incubated at room temperature for 10 min. 
The microplate was analyzed at 595 nm with a BioRad microplate reader; the absorbancy of each 
well was recorded and stored on a spreadsheet file. This assay was calibrated and there is a direct 
relationship between the absorbancy of the crystal violet dye associated with the cell and the 
number of viable cells (Figure 3) [75]. 
 The averaged absorbancy of the blank wells was subtracted from the absorbancy data from 
each well. The mean blank-corrected absorbancy value of the negative control was set at 100%. 
The absorbancy for each treatment group well was converted into a percentage of the negative 
control. This procedure normalized the data, maintained the variance and allowed the 
combination of data from multiple microplates. For each DBP concentration, 8 replicate wells 
were analyzed per experiment, and the experiments were repeated 2-4×. These data were used to 
generate a concentration-response curve for each DBP (Figure 4). Regression analysis was 
applied to each DBP concentration-response curve, which was used to calculate the %C½ value, 
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which is analogous to a LC50 value. The %C½ value is the calculated DBP concentration that 
induced a cell density that was 50% of the negative control (Figure 4).  
 The data from the cytotoxicity experiments were transferred to Excel spreadsheets and 
analyzed using the statistical and graphical functions of SigmaPlot 8.02, SigmaStat 3.1 and Table 
Curve 4.03 (Systat Software Inc., San Jose, CA). The crystal violet absorbancy data collected by 
the Bio-Rad microplate reader was saved as a text file (.txt) with the experiment number and 
transferred to an Excel spreadsheet. The original absorbancy data, the blank-corrected and the 
conversion to the percent of the negative control values were saved on the spreadsheet for each 
DBP analyzed. For each DBP, a summary page was prepared and all of the statistical data was 
conducted on the percent of the negative control values. A concentration-response cytotoxicity 
curve for each DBP was generated from the summary page and a one-way analysis of variance 
(ANOVA) test was conducted to determine if the DBP induced a significant level of cell killing 
at a specific concentration. If a significant F value of P ≤ 0.05 was obtained, a Holm-Sidak 
multiple comparison versus the control group analysis was conducted. The power of the test 
statistic (1−β) was maintained as ≥0.8 at α = 0.05.  
 
 
 
 
 
 
 
 
 
 
Scan on microplate reader at 
595 nm.
Blank correct data
co
nt
ro
l
bl
an
k DBP concentrations
Normalize data to a percentage of 
the concurrent negative control
Save data as a spreadsheet file
Figure 2. A stained microplate illustrating the CHO cell chronic cytotoxicity assay. The control 
(column 1) contained cells not exposed to the test compound. The blank column without cells 
was used to determine the absorbancy of the crystal violet histological dye that was not 
associated with cells and to normalize the absorbancy data. The DBP or test chemical was 
assayed from low concentration (column 3) to high concentration (column 12) with 8 replicate 
cultures per concentration.  
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Figure 3. Calibration of the CHO cell cytotoxicity assay. (A) Absorption spectrum of 
crystal violet in the range from 340–800 nm. The maximum absorbancy of crystal 
violet was between 585–595 nm. (B) A comparison of the number of cells per 
microplate well determined by Coulter counting or by the absorbancy after crystal 
violet stain. 
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CHO Single Cell Gel Electrophoresis (SCGE) Assay 
 SCGE is a molecular genetic assay that can quantitatively measure the level of genomic 
DNA damage induced in individual nuclei of cells [77-79]. The day before treatment, 4×104 
CHO cells were added to each microplate well in 200 μL of F12 + 5% FBS and incubated. The 
next day the cells were washed with Hank’s balanced salt solution (HBSS) and treated with a 
series of concentrations of a specific DBP in F12 medium without FBS in a total volume of 25 
μL for 4 h at 37°C, 5% CO2. The wells were covered with sterile AlumnaSeal™. With each 
experiment a negative control, a positive control (3.8 mM ethylmethanesulfonate, EMS) and 9 
concentrations of a specific DBP were conducted concurrently. After incubation the cells were 
washed 2× with HBSS and harvested with 50 μL of 0.01% trypsin + 53 μM EDTA. The trypsin 
was inactivated with 70 μL of F12 + FBS. To measure acute cytotoxicity a 10 μL aliquot of cell 
suspension was mixed with 10 μL of 0.05% trypan blue vital dye in phosphate-buffered saline 
(PBS) [80]. SCGE data were not used if the acute cytotoxicity exceeded 30%. Prior to the 
experiment clear microscope slides were coated with a layer of 1% normal melting point agarose 
prepared with deionized water and dried overnight. After cell treatment, the cell suspension from 
each well was embedded in a layer of low melting point agarose prepared with PBS and placed 
upon the slides. After the microgels solidified on a tray placed over ice, a final layer of 0.5% low 
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Figure 4. CHO cell chronic cytotoxicity concentration-response curve illustrating the 
determination of the %C½ value. This value is the calculated DBP concentration (based 
upon regression of the concentration-response data) that induced a cell density that was 
50% of the negative control and is analogous to the LC50 value. The R2 from the regression 
analysis was 0.99 and the %C½ value = 12.2 µM. 
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melting point agarose was placed upon the previous layers. The cellular membranes were 
removed by an overnight immersion in lysing solution at 4°C. The slides were placed in an 
alkaline buffer (pH 13.5) in an electrophoresis tank and the DNA was denatured for 20 min. The 
microgels were electrophoresed at 25 V, 300 mA (0.72 V/cm) for 40 min at 4°C. The microgels 
were removed from the tank, neutralized with Tris buffer, pH 7.5, rinsed in cold water, 
dehydrated in cold methanol, dried at 50°C and stored at room temperature in a covered slide 
box.  
 For microscopic analysis the microgels were hydrated in cold water for 20-30 min and 
stained with 65 μL of ethidium bromide (20 μg/mL) for 3 min. The microgels were rinsed in cold 
water and were analyzed with a Zeiss fluorescence microscope with an excitation filter of 546/10 
nm and a barrier filter of 590 nm. For each experiment 2 microgels were prepared per treatment 
group. Twenty-five randomly chosen nuclei were analyzed in each microgel using a charged 
coupled device camera. A computerized image analysis system (Komet version 3.1, Kinetic 
Imaging Ltd., Liverpool, UK) was employed to determine the tail moment (integrated value of 
migrated DNA density multiplied by the migration distance) of the nuclei as a measure of DNA 
damage. The digitalized data (Figure 5) were automatically transferred to a computer based 
spreadsheet for subsequent statistical analysis. The experiments were repeated 3 times for each 
DBP.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The SCGE tail moment data for each nucleus for each microgel was generated using the 
Komet 3.1 software. These data were stored on a spreadsheet and the median tail moment value 
for that microgel was calculated and transferred to a data spreadsheet. In addition the acute 
Figure 5. SCGE image illustrating genomic DNA damage in a nucleus after being 
electrophoresed in an agarose microgel. The level of DNA damage is directly related 
to the amount of DNA that migrates in the microgel (tail). The calipers are from a 
computer program for the assay that measures the amount and distance of DNA 
migration. 
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cytotoxicity of the treated cells was entered into the same data spreadsheet. Within the DBP 
concentration range that allowed for 70% or greater viable cells, a concentration-response curve 
was generated. The data were plotted and a regression analysis was used to fit the curve (Figure 
6). The SCGE genotoxic potency value was calculated for each DBP. The SCGE genotoxic 
potency value was determined from the concentration-response curve. It represents the midpoint 
of the curve within the concentration range that expressed above 70% cell viability. 
 The data were transferred to the SigmaStat 3.1 program spreadsheet for an ANOVA 
statistical test. The tail moment values in the SCGE assay are not normally distributed and 
violate the requirements for analysis by parametric statistics. The median tail moment value for 
each microgel was determined as described above and the data were averaged amongst all of the 
microgels for each DBP concentration. Averaged median or mean values express a normal 
distribution according to the central limit theorem [81]. The averaged median tail moment values 
obtained from repeated experiments were analyzed with a one-way ANOVA test [82]. If a 
significant F value of P ≤0.05 was obtained, a Holm-Sidak multiple comparison versus the 
control group analysis was conducted. The power of the test statistic (1−β) was maintained as 
≥0.8 at α=0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. CHO cell SCGE genotoxicity concentration-
response curve for dibromoacetamide. 
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Safety 
 Safety is a principal concern in the laboratory. Manipulations of toxic, genotoxic and/or 
carcinogenic chemicals were conducted using disposable papers and gloves in a certified stage 
two containment biological/chemical safety hood. The disposal of hazardous material was in 
compliance with the University of Illinois regulations. All staff involved on this project received 
safety training under the auspices of the University of Illinois Institutional Biological Safety 
Committee. The regulations of the Division of Research Safety of the University of Illinois were 
implemented throughout this project. Experimental designs for each DBP analyzed were 
prepared in hard-copy data books. The information for each experiment, identified by a unique 
experiment number, was placed in a file within an Excel spreadsheet.  
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Results and Discussion 
 
Haloacetonitriles 
 The haloacetonitriles were measured in several occurrence studies [50, 51, 83-85] with 
bromochloroacetonitrile, chloroacetonitrile, dibromoacetonitrile, and trichloroacetonitrile 
(HAN4) the most commonly measured species. In the U.S. EPA’s Information Collection Rule 
(ICR), the haloacetonitriles (HAN4) ranged from <0.5 to 41.0 µg/L, and were generally 12% of 
the levels of the four regulated trihalomethanes. These haloacetonitriles were formed using 
chlorine and/or chloramine disinfection; plants using chloramines (with and without chlorine) 
had the highest levels. Higher haloacetonitrile levels were from distribution system waters 
treated with post-chloramination versus free chlorine. Seven halonitriles were evaluated in this 
study, bromoacetonitrile, bromochloroacetonitrile, chloroacetonitrile, dibromoacetonitrile, 
dichloroacetonitrile, iodoacetonitrile, and trichloroacetonitrile (Table 1). 
  
CHO Cell Cytotoxicity Analysis of the Haloacetonitriles 
 The CHO cell chronic cytotoxicity of the seven halonitriles analyzed in this study are 
presented in Table 2. In the table, the lowest concentration of a specific haloacetonitrile was 
identified by the ANOVA test statistic that induced a significant toxic response as compared to 
their concurrent negative controls. The %C½ value was the concentration of the haloacetonitrile 
that induced a 50% reduction of the cell density as compared to the negative controls. Finally, the 
R2 refers to the fit of the regression analysis from which the %C½ value was calculated. All 
concentrations are presented in molar (M) units of measure. 
 
Table 2. CHO cell chronic cytotoxicity of the haloacetonitrile DBPs and related chemicals. 
Compound Lowest Tox. 
Conc. (M) 
R2 %C½ (M) ANOVA Test Statistic 
Bromoacetonitrile 1.0 × 10⎯6 0.98 3.21 × 10⎯6 F11,228 = 98.3; P ≤ 0.001 
Bromochloroacetonitrile 7.0 × 10⎯6 0.96 8.46 × 10⎯6 F11,171 = 36.2; P ≤ 0.001 
Chloroacetonitrile 5.0 × 10⎯5 0.99 6.83 × 10⎯5 F13,188 = 65.9; P ≤ 0.001 
Dibromoacetonitrile 1.0 × 10⎯6 0.99 2.85 × 10⎯6 F11,179 = 271.5; P ≤ 0.001 
Dichloroacetonitrile 1.0 × 10⎯5 0.99 5.73 × 10⎯5 F10,171 = 63.4; P ≤ 0.001 
Iodoacetonitrile 1.0 × 10⎯7 0.98 3.30 × 10⎯6 F12,163 = 148.4; P ≤ 0.001 
Trichloroacetonitrile 2.5 × 10⎯5 0.93 1.60 × 10⎯4 F17,282 = 36.8; P ≤ 0.001 
 
 A comparison of the relative cytotoxicity of the halonitriles analyzed in this study is 
presented in Figure 7. The lowest concentration that induced a significant cytotoxic response 
ranged from 100 nM (iodoacetonitrile) to 50 µM (chloroacetonitrile) (Table 2). The %C½ values 
ranged from 2.85 µM (dibromoacetonitrile) to 160 µM (trichloroacetonitrile). The rank order for 
cytotoxicity (highest to lowest) based on the %C½ values was dibromoacetonitrile > 
bromoacetonitrile > ≈ iodoacetonitrile > bromochloroacetonitrile > dichloroacetonitrile > 
chloroacetonitrile > trichloroacetonitrile. 
 
CHO Cell Genotoxicity Analysis of the Haloacetonitriles 
 In this study seven halonitriles were analyzed for their ability to induce genomic DNA 
damage in CHO cells; the results are presented in Table 3. In the table, the lowest concentration 
of a specific haloacetonitrile was identified by the ANOVA test statistic that induced significant 
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genomic DNA strand breakage (as measured by SCGE median tail moment values) as compared 
to their concurrent negative controls. The SCGE genotoxic potency value was calculated for each 
chemical from the concentration-response curve. It represents the midpoint of the curve within 
the concentration range that expressed above 70% cell viability of the treated cells. Finally, the 
R2 refers to the fit of the regression analysis from which the SCGE genotoxic potency value was 
calculated. All concentrations are presented in molar (M) units of measure. 
 
 
 
Table 3. CHO cell genotoxicity of the haloacetonitrile DBPs and related chemicals. 
Compound Lowest 
Genotox. 
Conc. (M) 
R2 SCGE Gen. 
Potency (M)
ANOVA Test Statistic 
Bromoacetonitrile 4.00 × 10⎯5 0.99 3.85 × 10⎯5 F6, 36 = 32.7; P ≤ 0.001 
Bromochloroacetonitrile 2.50 × 10⎯4 0.98 3.24 × 10⎯4 F10, 41 = 19.1; P ≤ 0.001 
Chloroacetonitrile 2.50 × 10⎯4 0.99 6.01 × 10⎯4 F11,42 = 28.9; P ≤ 0.001 
Dibromoacetonitrile 3.00 × 10⎯5 0.95 2.97 × 10⎯5 F9, 46 = 46.1; P ≤ 0.001 
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Figure 7. Comparison of the concentration-response curves for the CHO cell chronic 
cytotoxicity of seven haloacetonitriles. 
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Dichloroacetonitrile 2.40 × 10⎯3 0.98 2.75 × 10⎯3 F17,62 = 14.2; P ≤ 0.001 
Iodoacetonitrile 3.00 × 10⎯5 0.98 3.71 × 10⎯5 F10, 53 = 46.6; P ≤ 0.001 
Trichloroacetonitrile 1.00 × 10⎯3 0.98 1.01 × 10⎯3 F7, 32 = 30.5; P ≤ 0.001 
 
 The lowest concentration that induced a significant SCGE genotoxic response ranged 
from 30 µM (iodoacetonitrile or dibromoacetonitrile) to 2.4 mM (dichloroacetonitrile). The 
SCGE genotoxic potency value ranged from 29.7 µM (dibromoacetonitrile) to 2.75 mM 
(dichloroacetonitrile) (Table 3). The rank order of genotoxic potency from most potent to least 
was dibromoacetonitrile > iodoacetonitrile ≈ bromoacetonitrile > bromochloroacetonitrile > 
chloroacetonitrile > trichloroacetonitrile > dichloroacetonitrile. A comparison of the genotoxicity 
for these halonitriles is presented in Figure 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Haloacetamides 
 Haloacetamides have been identified as DBPs from drinking water treatment plants and 
from laboratory studies [61, 62, 86]. Thirteen haloamides were evaluated in this study, 
bromoacetamide, bromochloroacetamide, bromodichloroacetamide, bromoiodoacetamide, 
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Figure 8. Comparison of the SCGE genotoxicity concentration-response curves of seven 
haloacetonitriles.  
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chloroacetamide, chloroiodoacetamide, dibromoacetamide, dibromochloroacetamide, 
dichloroacetamide, diiodoacetamide, iodoacetamide, tribromoacetamide, and trichloroacetamide 
(Table 1).  
 
CHO Cell Cytotoxicity Analysis of the Haloacetamides 
 The CHO cell chronic cytotoxicity of the 13 haloacetamides analyzed in this study are 
presented in Table 4. In the table, the lowest concentration of a specific haloacetamide was 
identified by the ANOVA test statistic that induced a significant toxic response as compared to 
their concurrent negative controls. The %C½ value was the concentration of the haloacetamide 
that induced a 50% reduction of the cell density as compared to the negative controls. Finally, the 
R2 refers to the fit of the regression analysis from which the %C½ value was calculated. All 
concentrations are presented in molar (M) units of measure.A comparison of the relative 
cytotoxicity of the haloacetamides analyzed in this study is presented in Figure 9. 
 The lowest concentration that induced a significant cytotoxic response ranged from 25 nM 
(diiodoacetamide) to 800 μM (dichloroacetamide) (Table 4). The %C½ values ranged from 678 
nM (diiodoacetamide) to 2.05 mM (trichloroacetamide). The rank order for cytotoxicity (highest 
to lowest) of the 13 haloacetamides based on their %C½ values was diiodoacetamide > 
iodoacetamide > bromoacetamide > tribromoacetamide > bromoiodoacetamide > 
dibromochloroacetamide > chloroiodoacetamide > bromodichloroacetamide  > 
dibromoacetamide > bromochloroacetamide > chloroacetamide > dichloroacetamide > 
trichloroacetamide. 
 
Table 4. CHO cell chronic cytotoxicity of the haloacetamide DBPs and related chemicals. 
Compound Lowest Tox. 
Conc. (M) 
R2 %C½ (M) ANOVA Test Statistic 
Bromoacetamide 5.00×10−7 0.99 1.89×10−6 F12, 282 = 57.15; P ≤ 0.001 
Bromochloroacetamide 1.00×10−6 0.96 1.71×10−5 F16, 183 = 111.05; P ≤ 0.001 
Bromodichloroacetamide 2.00×10−6 0.98 8.68×10−6 F10, 197 = 173.96; P ≤ 0.001 
Bromoiodoacetamide 2.00×10−6 0.98 3.81×10−6 a F10, 164 = 85.99; P ≤ 0.001 
Chloroacetamide 7.50×10−5 0.98 1.48×10−4 F13, 176 = 99.20; P ≤ 0.001 
Chloroiodoacetamide 2.00×10−6 0.96 5.97×10−6 F14, 193 = 111.78; P ≤ 0.001 
Dibromoacetamide 2.50 ×10−6 0.99 1.22×10−5 F11, 283 = 174.56; P ≤ 0.001 
Dibromochloroacetamide 1.00×10−6 0.96 4.75×10−6 F9, 174 = 40.56; P ≤ 0.001 
Dichloroacetamide 8.00×10−4 0.95 1.92×10−3 F12, 271 = 79.20; P ≤ 0.001 
Diiodoacetamide 2.50×10–8 0.98 6.78×10−7 F10, 149 = 144.35; P ≤ 0.001 
Iodoacetamide 5.00×10−7 0.98 1.42×10−6 F17, 332 = 133.23; P ≤ 0.001 
Tribromoacetamide 2.00×10−6 0.97 3.14×10−6 F10, 275 = 122.62; P ≤ 0.001 
Trichloroacetamide 5.00×10−4 0.96 2.05×10−3 F11, 251 = 77.05; P ≤ 0.001 
 
a The calculated %C½ value for bromoiodoacetamide alone assuming an additive model for the 
diiodoacetamide  and dibromoacetamide contaminants was 3.35 × 10−6 M.  
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CHO Cell Genotoxicity Analysis of the Haloacetamides 
 In this study13 haloacetamides were analyzed for their ability to induce genomic DNA 
damage in CHO cells; the results are presented in Table 5. In the table, the lowest concentration 
of a specific haloacetamide was identified by the ANOVA test statistic that induced significant 
genomic DNA strand breakage (as measured by SCGE median tail moment values) as compared 
to their concurrent negative controls. The SCGE genotoxic potency value was calculated for each 
chemical from the concentration-response curve. It represents the midpoint of the curve within 
the concentration range that expressed above 70% cell viability of the treated cells. Finally, the 
R2 refers to the fit of the regression analysis from which the SCGE genotoxic potency value was 
calculated. All concentrations are presented in molar (M) units of measure. 
 
Haloacetamides (M)
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 Figure 9. Comparison of the concentration-response curves for the CHO cell chronic 
cytotoxicity of the haloacetamides. The abbreviations are DIAcAm = diiodoacetamide, 
IAcAm = iodoacetamide, BIAcAm = bromoiodoacetamide, CIAcAm = chloroiodoacetamide, 
BAcAm = bromoacetamide, DBAcAm = dibromoacetamide, TBAcAm = tribromoacetamide, 
BCAcAm =  bromochloroacetamide, DBCAcAm = dibromochloroacetamide, BDCAcAm = 
bromodichloroacetamide, CAcAm = chloroacetamide, DCAcAm = dichloroacetamide, and 
TCAcAm = trichloroacetamide. 
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Table 5. CHO cell genotoxicity of the haloacetamide DBPs and related chemicals. 
Compound Lowest 
Genotox. 
Conc. (M) 
R2 SCGE Gen. 
Potency (M)
ANOVA Test Statistic 
Bromoacetamide 2.50×10−5 0.99 3.68×10−5 F9, 38 = 29.77; P ≤ 0.001 
Bromochloroacetamide 4.00×10−4 0.99 5.83×10−4 F9, 48 = 53.86; P ≤ 0.001 
Bromodichloroacetamide 7.50×10−5 0.99 1.46×10−4 F9, 39 = 58.41; P ≤ 0.001 
Bromoiodoacetamide 2.50×10−5 0.99 7.21×10−5 a F10, 54 = 29.38; P ≤ 0.001 
Chloroacetamide 7.50×10−4 0.99 1.38×10−3 F11, 46 = 25.02; P ≤ 0.001 
Chloroiodoacetamide 2.00×10−4 0.99 3.02×10−4 F17, 62 = 35.19; P ≤ 0.001 
Dibromoacetamide 5.00×10−4 0.99 7.44×10−4 F10, 47 = 21.09; P ≤ 0.001 
Dibromochloroacetamide 2.50×10−5 0.98 6.94×10−5 F8, 37 = 185.59; P ≤ 0.001 
Dichloroacetamide NA NA NS >1×10−2 F11, 34 = 1.026; P = 0.417 
Diiodoacetamide 2.50×10−5 0.98 3.39×10−5 F11, 60 = 29.12; P ≤ 0.001 
Iodoacetamide 3.00×10−5 0.99 3.41×10−5 F15, 43 = 13.11; P ≤ 0.001 
Tribromoacetamide 3.00×10−5 0.97 3.25×10−5 F17, 62 = 35.19; P ≤ 0.001 
Trichloroacetamide 5.00×10−3 0.98 6.54×10−3 F9, 50 = 5.75; P ≤ 0.001 
NS = not statistically different from the negative control, NA = non applicable. a The calculated SCGE 
genotoxic potency value for bromoiodoacetamide alone assuming an additive model for the 
diiodoacetamide and dibromoacetamide contaminants was 1.62 × 10−5 M. 
 
 A comparison of the CHO cell genotoxicity for these haloacetamides is presented in 
Figure 10. The lowest concentration that induced a significant SCGE genotoxic response ranged 
from 25 μM for diiodoacetamide, bromoiodoacetamide, bromoacetamide, and 
dibromochloroacetamide to 5 mM for trichloroacetamide. The SCGE genotoxic potency value 
ranged from 32.5 μM for tribromoacetamide to 6.5 mM for trichloroacetamide (Table 5). The 
rank order of genotoxic potency from most potent to least was tribromoacetamide > 
diiodoacetamide ≈ iodoacetamide > bromoacetamide > dibromochloroacetamide > 
bromoiodoacetamide > bromodichloroacetamide > chloroiodoacetamide > 
bromochloroacetamide > dibromoacetamide > chloroacetamide > trichloroacetamide. 
Dichloroacetamide was not genotoxic (Table 5). 
 20
 
Haloacetaldehydes 
 The aldehydes are toxic DBPs and several were measured in the ICR report, including 
formaldehyde, acetaldehyde, glyoxal, methylglyoxal, and trichloroacetaldehyde (chloral hydrate). 
Although the non-halogenated aldehydes are DBPs produced primarily by ozone treatment [9, 
87], chlorine and chlorine dioxide treatment can form formaldehyde [9, 65, 85]. The 
haloaldehydes evaluated in this study were chloroacetaldehyde, dibromoacetaldehyde, 
dichloroacetaldehyde, tribromoacetaldehyde, and trichloroacetaldehyde (Table 1). 
 
CHO Cell Cytotoxicity Analysis of the Haloacetaldehydes 
 The CHO cell chronic cytotoxicity of the five haloacetaldehydes analyzed in this study 
are presented in Table 6. In the table, the lowest concentration of a specific haloacetaldehyde was 
identified by the ANOVA test statistic that induced a significant toxic response as compared to 
their concurrent negative controls. The %C½ value was the concentration of the 
haloacetaldehyde that induced a 50% reduction of the cell density as compared to the negative 
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Figure 10. Comparison of the SCGE genotoxicity concentration-response curves of 13 
haloacetamides. The abbreviations are IAcAm = iodoacetamide, DIAcAm = 
diiodoacetamide, BIAcAm = bromoiodoacetamide, CIAcAm = chloroiodoacetamide, 
BAcAm = bromoacetamide, DBAcAm = dibromoacetamide, TBAcAm = 
tribromoacetamide, BCAcAm = bromochloroacetamide, DBCAcAm = 
dibromochloroacetamide, BDCAcAm = bromodichloroacetamide, CAcAm = 
chloroacetamide, DCAcAm = dichloroacetamide, and TCAcAm = trichloroacetamide. 
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controls. Finally, the R2 refers to the fit of the regression analysis from which the %C½ value 
was calculated. All concentrations are presented in molar (M) units of measure. A comparison of 
the relative cytotoxicity of the haloacetaldehydes analyzed in this study is presented in Figure 11. 
 
 
Table 6. CHO cell chronic cytotoxicity of the haloacetaldehyde DBPs and related chemicals. 
Compound Lowest Tox. 
Conc. (M) 
R2 %C½ (M) ANOVA Test Statistic 
Chloroacetaldehyde 5.00×10−7 0.99 3.60×10−6 F11, 176 = 240.7; P ≤ 0.001 
Dibromoacetaldehyde 2.00×10−6 0.99 4.70×10−6 F10, 177 = 164.8; P ≤ 0.001 
Dichloroacetaldehyde 8.00×10−6 0.91 2.93×10−5 F19, 328 = 36.1; P ≤ 0.001 
Tribromoacetaldehyde 2.00×10−6 0.99 3.58×10−6 F18, 102 = 42.8; P ≤ 0.001 
Trichloroacetaldehyde 3.75×10−4 0.94 1.16×10−3 F24, 333 = 33.9; P ≤ 0.001 
  
 The lowest concentration that induced a significant cytotoxic response ranged from 0.5 
μM (chloroacetaldehyde) to 375 μM (trichloroacetaldehyde) (Table 6). The %C½ values ranged 
from 3.58 μM (tribromoacetaldehyde) to 1.16 mM (trichloroacetaldehyde). Based on the %C½ 
values the rank order for cytotoxicity was tribromoacetaldehyde ≈ chloroacetaldehyde > 
dibromoacetaldehyde > dichloroacetaldehyde >> trichloroacetaldehyde.  
 
Figure 11. Comparison of the concentration-response curves for the CHO cell chronic 
cytotoxicity of the haloacetaldehydes. 
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CHO Cell Genotoxicity Analysis of the Haloacetaldehydes 
 In this study five haloacetaldehydes were analyzed for their ability to induce genomic DNA 
damage in CHO cells; the results are presented in Table 7. In the table, the lowest concentration 
of a specific haloacetaldehyde was identified by the ANOVA test statistic that induced significant 
genomic DNA strand breakage (as measured by SCGE median tail moment values) as compared 
to their concurrent negative controls. The SCGE genotoxic potency value was calculated for each 
chemical from the concentration-response curve. It represents the midpoint of the curve within 
the concentration range that expressed above 70% cell viability of the treated cells. Finally, the 
R2 refers to the fit of the regression analysis from which the SCGE genotoxic potency value was 
calculated. All concentrations are presented in molar (M) units of measure. 
 
 
Table 7. CHO cell genotoxicity of the haloacetaldehyde DBPs and related chemicals. 
Compound Lowest 
Genotox. 
Conc. (M) 
R2 SCGE Gen. 
Potency (M)
ANOVA Test Statistic 
Chloroacetaldehyde 1.25×10−4 0.98 1.59×10−4 F9, 58 = 56.7; P ≤ 0.001 
Dibromoacetaldehyde 1.00×10−4 0.98 1.64×10−4 F8, 43 = 55.7; P ≤ 0.001 
Dichloroacetaldehyde 7.00×10−4 0.96 8.83×10−4 F21, 88 = 31.9; P ≤ 0.001 
Tribromoacetaldehyde 2.50×10−4 0.97 3.55×10−4 F11, 64 = 70.99; P ≤ 0.001 
Trichloroacetaldehyde NS 
−
NS F20, 37 = 1.2; P = 0.29 
NS = not statistically different from the negative control.  
 
 A comparison of the CHO cell genotoxicity for these agents is presented in Figure 12. 
The lowest concentration that induced a significant SCGE genotoxic response ranged from 100 
µM for dibromoacetaldehyde to 700 µM for dichloroacetaldehyde. The SCGE genotoxic potency 
value ranged from 159 µM for chloroacetaldehyde to 883 µM for dichloroacetaldehyde (Table 7). 
The rank order of genotoxic potency from most to least potent was chloroacetaldehyde ≈ 
dibromoacetaldehyde > tribromoacetaldehyde > dichloroacetaldehyde. Trichloroacetaldehyde 
was not genotoxic (Figure 12). 
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Conclusion 
 A comparative, in vitro analysis that measured chronic cytotoxicity and acute genomic 
DNA damage in CHO cells of three chemical classes of emerging DBPs was conducted. The N-
DBPs (haloacetonitriles and haloacetamides) and a C-DBP class (haloacetaldehydes) were 
evaluated such that a rank order of their chronic cytotoxicity to CHO cells was generated. For the 
haloacetonitriles the cytotoxicity from most toxic to least toxic was dibromoacetonitrile > 
bromoacetonitrile > ≈ iodoacetonitrile > bromochloroacetonitrile > dichloroacetonitrile > 
chloroacetonitrile > trichloroacetonitrile. The cytotoxicity order for the haloacetamides was 
diiodoacetamide > iodoacetamide > bromoacetamide > tribromoacetamide > 
bromoiodoacetamide > dibromochloroacetamide > bromochloroacetamide > 
chloroiodoacetamide > bromodichloroacetamide > dibromoacetamide > chloroacetamide > 
dichloroacetamide > trichloroacetamide. Finally the order of cytotoxicity for the 
haloacetaldehydes was tribromoacetaldehyde ≈ chloroacetaldehyde > dibromoacetaldehyde > 
dichloroacetaldehyde >> trichloroacetaldehyde. The induction of genomic DNA damage by these 
DBPs was quantitatively measured using SCGE analysis. The rank order for the genotoxicity of 
the haloacetonitriles was iodoacetonitrile > bromoacetonitrile ≈ dibromoacetonitrile > 
bromochloroacetonitrile > chloroacetonitrile > trichloroacetonitrile > dichloroacetonitrile. The 
rank order for the genotoxicity of the haloacetamides was tribromoacetamide > diiodoacetamide 
Figure 12. Comparison of the SCGE genotoxicity concentration-response curves of the 
haloacetaldehydes. 
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≈ iodoacetamide > bromoacetamide > dibromochloroacetamide > bromoiodoacetamide > 
bromodichloroacetamide > chloroiodoacetamide > bromochloroacetamide > dibromoacetamide 
> chloroacetamide > trichloroacetamide with dichloroacetamide not genotoxic. The genotoxic 
rank order for the haloacetaldehydes was chloroacetaldehyde ≈ dibromoacetaldehyde > 
tribromoacetaldehyde > dichloroacetaldehyde. Trichloroacetaldehyde was not genotoxic. These 
data demonstrate the wide range of responses by these emerging and important DBPs. The 
selection of these three DBP classes was based on information from the U.S. EPA DBP priority 
study [74] and the U.S. EPA Nationwide Occurrence Study [50]. Mammalian cell cytotoxicity 
and genotoxicity data provided a rank ordering of the relational toxicities of regulated and 
emerging DBPs and related agents both within an individual chemical class and among classes. 
The use of alternative disinfectants generates new DBP compounds and alters the distribution of 
DBP chemical classes. The water supply community will be able to consider these factors when 
employing alternatives to chlorine disinfection. In addition these data will be available to 
prioritize DBPs for future in vivo toxicological studies and risk assessment. 
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